long intergenic non-protein coding RNA 2739Genealiases: []
Q-omics provides the consensus-scored LINC02739 profile across patient tissues and cancer cell-line models. LINC02739 expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, LINC02739 is differentially expressed in 12, with the highest sampling consensus in HNSC. Additionally, LINC02739 RNA expression shows 14,085 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight KIRC, HNSC, and THYM as cancer lineages where LINC02739 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02739 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02739 survival associations across molecular data types. LINC02739 RNA expression shows survival associations in the most cancer types (21). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02739 RNA expression–survival associations across cancer types. High LINC02739 expression shows unfavorable associations in KIRC, LUAD, READ and PAAD, but favorable associations in ACC and BRCA. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for LINC02739 RNA expression.
This table summarizes LINC02739 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02739. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02739 shows lower tumor expression in BRCA and UCEC and higher tumor expression in HNSC, LIHC, KIRP and CHOL. The HNSC box plot shows higher LINC02739 RNA expression in tumor versus normal tissue (log2 FC = +0.178, t-test p = .010).
This table shows molecular features associated with LINC02739 in patient tissues and cancer cell lines. In patient samples, LINC02739 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
